Hip joint failure is a debilitating condition that can significantly hinder quality of life. Traditional treatments often involve surgery, but there is growing interest in using stem cells to repair damaged hip cartilage. Stem cell therapy offers the potential for non-surgical treatment with the goal of reducing pain. Researchers are actively expl

Digi Communications intends to suggest to shareholders the distribution of dividends to the fiscal 12 months 2023 within the upcoming common Assembly of Shareholders, which shall occur in June 2024 GenQual and R-Pharm collaborate to deliver predictive diagnostics for novel anti-IL-six antibody for autoimmune illnesses All subscriptions involve on